Adelaide University (University of South Australia, formerly) | Australia
Dr. Mohamed Amen is a Postdoctoral Researcher at Adelaide University, specialising in the development and translation of nanoscale sensor technologies for biomedical applications. With a strong foundation in biomedical and biomaterial engineering, his work focuses on the design of solid-state field-effect transistors for high-sensitivity biosignal monitoring and point-of-care diagnostics. His research aims to bridge advanced nanotechnology with clinical applications, addressing critical healthcare challenges such as heart failure, traumatic brain injury, preeclampsia, and epilepsy. Dr. Amen has made significant contributions to the field of wearable and implantable diagnostic devices, leveraging microfabrication and nanotechnology platforms to create novel biosensors capable of real-time monitoring of physiological signals. His research combines engineering expertise with translational potential, exemplified by the development of rapid finger-prick tests and wearable ECG systems that are moving toward clinical evaluation and patent protection. His work has attracted industry collaboration, including engagement with leading healthcare technology partners, underscoring the practical impact of his innovations. To date, he has published numerous peer-reviewed articles in high-impact journals and has contributed to several consultancy and industrial projects. His research is highly cited, reflecting its global relevance and scientific influence. He is also an active member of professional societies, including the Australian Materials Research Society and the Australia and New Zealand Nano & Microfluidic Society, fostering collaboration and knowledge exchange within the scientific community. Dr. Amen’s work exemplifies research excellence through its combination of cutting-edge innovation, translational application, and community impact. His ongoing projects aim to revolutionize point-of-care diagnostics and wearable biosensing, with the ultimate goal of improving early disease detection, patient outcomes, and global healthcare delivery. His dedication to advancing biomedical nanotechnology positions him as a leading researcher in the integration of solid-state nanosensors into practical clinical tools.
Citation Metrics (Google Scholar)
Citations
h-index
i10index
View Google Scholar Profile
Featured Publications